Medable Newsroom

Medable reports 80% revenue growth from portfolio-level eCOA adoption in 2024, reflecting growing confidence in scalable digital solutions for clinical trials.

Medable, a leading provider of clinical development technology, today announced a collaboration with Google Cloud to bring Medable’s Digital andDecentralized Clinical Trial Platform to Google Cloud Marketplace.

‍

Clinical research industry’s largest, most diverse global network of patient advocates improves the trial experience across therapeutic areas and technologies

‍

Medable is partnering with industry leader Masimo to bring best-in-class medical-grade wearable devices to clinical research.

‍

The Phase IV trial, funded by a top-10 global pharmaceutical company, had a narrow recruitment window to enroll patients suffering from Anemia in End Stage Kidney Disease (ESKD) across more than 40 dialysis centers, involving 476 site users.

‍

Medable announces results from a new research project with Duke University BASE Lab on enhanced electronic informed consent (eIC) in clinical trials.

‍

Steve Jones, Medable’s vice president of data analytics, achieved the silver award in the Decentralized Solutions Individual of the Year category at PharmaTimes International Clinical Researcher of the Year awards gala in London on May 18, 2023.

‍

Medable's decentralized clinical trial (DCT) platform was selected by the Nova Scotia Health Innovation Hub to increase the accessibility of oncology care for remote patients in rural Nova Scotia, with the long-term aim to improve patient access and trial diversity across Canada.

Medable, the industry-leading technology platform for patient-centered clinical trials, today announced a partnership with non-profit Every Cure, which officially launched in September in partnership with the Clinton Global Initiative to scale up an innovative “drug repurposing” research approach to identify treatments for rare diseases.